Kaiser names new CEO for Maui Health System
Maui Health System, the Kaiser Permanente Hawaii entity that took over operation of three state-owned hospitals in Maui County earlier this month, has named Michael Rembis CEO and hospital administrator. Rembis, who starts his new job on Aug. 21, comes to Maui from Paladin Healthcare Management, where he was CEO, and Avanti Hospitals where was also CEO and provided leadership for Memorial Hospital of Gardena, Community Hospital of Huntington Park, Coast Plaza Hospital, and East Los Angeles Doctors … (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - August 1, 2017 Category: American Health Authors: Janis L. Magin Source Type: news

Kaiser names new CEO for Maui Health System
Maui Health System, the Kaiser Permanente Hawaii entity that took over operation of three state-owned hospitals in Maui County earlier this month, has named Michael Rembis CEO and hospital administrator. Rembis, who starts his new job on Aug. 21, comes to Maui from Paladin Healthcare Management, where he was CEO, and Avanti Hospitals where was also CEO and provided leadership for Memorial Hospital of Gardena, Community Hospital of Huntington Park, Coast Plaza Hospital, and East Los Angeles Doctors … (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 1, 2017 Category: Biotechnology Authors: Janis L. Magin Source Type: news

Huntington Bank CEO says gridlock in Washington is holding the economy back
Huntington Bank ’s CEO is concerned about uncertainties in tax policy, health care (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - July 24, 2017 Category: American Health Authors: Jeremy Hill Source Type: news

Wave Life Sciences begins Phase Ib/IIa trials of two Huntington ’s disease drugs
Wave Life Sciences has begun new Phase Ib/IIa clinical trials (PRECISION-HD1 and PRECISION-HD2) of WVE-120101 and WVE-120102 to treat patients suffering with Huntington ’s disease (HD). (Source: Drug Development Technology)
Source: Drug Development Technology - July 17, 2017 Category: Pharmaceuticals Source Type: news

New data network for Huntington's disease research
(University of Plymouth) An international team has created the first data network for research into Huntington's disease, freely available to all scientists in this field. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 13, 2017 Category: International Medicine & Public Health Source Type: news

Nuredis Appoints Julie Anne Smith as Chief Executive Officer to Lead Neurodegenerative Disease Company
MENLO PARK, Calif., July 11, 2017 -- (Healthcare Sales & Marketing Network) -- Nuredis, Inc., a biotechnology company developing novel therapies to treat inherited neurodegenerative diseases caused by nucleotide repeat expansions, today announced the appo... Biopharmaceuticals, Neurology, Personnel Nuredis, Huntington's Disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 11, 2017 Category: Pharmaceuticals Source Type: news

Rapid Switch to Deutetrabenazine Safe in Huntington's (CME/CE)
(MedPage Today) -- Chorea control maintained after overnight drug swap (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - July 11, 2017 Category: Primary Care Source Type: news

Scientists deploy GM sheep in fight to treat Huntington ’s disease
Transgenic flock brought to UK for research into incurable brain condition, which affects more than 6,700 people in the countryScientists at Cambridge University have co-opted an unusual ally in their battle to find treatments for an incurable degenerative ailment that affects thousands of people in the UK. They have taken charge of a flock of merino sheep that have been genetically modified to carry the gene for Huntington ’s disease.The research, led by neuroscientist Professor Jenny Morton, aims to understand how to pinpoint early symptoms of the brain condition, which affects more than 6,700 people in the UK.Cont...
Source: Guardian Unlimited Science - July 8, 2017 Category: Science Authors: Robin McKie Observer science editor Tags: Medical research Neuroscience Genetics UK news Source Type: news

Long-term Safety of Deutetrabenazine for Chorea Confirmed Long-term Safety of Deutetrabenazine for Chorea Confirmed
Deutetrabenazine used to treat chorea in patients with Huntington's disease appears to be safe over the long term, with stabilization of motor symptoms at 1 year, results of an extension trial show.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 5, 2017 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

BioVentrix raises $15m
BioVentrix raised $14.5 million in a new round of equity financing according to an SEC filing posted this week. Funds in the round came from 152 unnamed investors, with the 1st sale marked on July 21, 2016, according to the filing. The company is not seeking anymore funds the round. The company raised the money through the sale of equity and convertible notes, according to the filing. A total of $1.2 million were provided as sales commissions, with the placement agent also receiving warrants to purchase common stock equal to 10% of the number of shares offered in the round at an exercise price of $7.50 per share, according...
Source: Mass Device - July 3, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News BioVentrix Source Type: news

Lily's Place: The heart of the heroin epidemic
Lily's Place, in Huntington, West Virginia, treats babies born exposed to drugs. Here, mothers learn to balance their addiction and recovery with motherhood. (Source: CNN.com - Health)
Source: CNN.com - Health - June 29, 2017 Category: Consumer Health News Source Type: news

Mitoconix Bio Raises $20 Million in Series A Funding to Develop Neurodegenerative Disease Therapies
Proceeds will be used to advance the Company's lead product through preclinical and clinical development and expand its therapeutic pipeline for treating neurodegenerative disorders by improving mitochondrial function NESS ZIONA, Israel, June 27, 2017 -... Biopharmaceuticals, Neurology, Venture Capital Mitoconix Bio, Huntington's disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 27, 2017 Category: Pharmaceuticals Source Type: news

Detecting diluteness
(Washington University in St. Louis) Engineers at Washington University in St. Louis and Princeton University developed a new way to dive into the cell's tiniest and most important components. What they found inside membraneless organelles surprised them, and could lead to better understanding of fatal diseases including cancer, Huntington's and ALS. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - June 26, 2017 Category: Biology Source Type: news

Medical News Today: Gene editing technique reverses Huntington's in mouse model
Huntington's is a progressive neurological condition; there is no cure. Recent advances in gene editing techniques offer new hope. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 20, 2017 Category: Consumer Health News Tags: Huntington's Disease Source Type: news

Genetic modifier for Huntington's disease progression identified
(University College London) A team led by UCL and Cardiff University researchers has developed a novel measure of disease progression for Huntington's disease, which enabled them to identify a genetic modifier associated with how rapidly the disease progresses. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - June 20, 2017 Category: Biology Source Type: news

Blood test predicts Huntington's disease risk finds UCL
Researchers from around the world, including University College London, unveiled a test that measures a protein released by damaged brain cells and predicts treatment success. (Source: the Mail online | Health)
Source: the Mail online | Health - June 12, 2017 Category: Consumer Health News Source Type: news

Blood test predicts Huntington's disease risk
Researchers from around the world, including University College London, unveiled a test that measures a protein released by damaged brain cells and predicts treatment success. (Source: the Mail online | Health)
Source: the Mail online | Health - June 12, 2017 Category: Consumer Health News Source Type: news

Huntington's disease trial test is 'major advance'
It could be faster and cheaper than current methods, researchers say. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - June 8, 2017 Category: Consumer Health News Source Type: news

FDA Eyeing Patient-Reported Outcomes in Huntington's, Parkinson's
(MedPage Today) -- Some non-motor symptoms may be ideal'PRO'candidates (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - June 6, 2017 Category: Geriatrics Source Type: news

Huntington ’s disease: the pope steps in to help raise awareness
A papal audience for families affected by the inherited brain disease could end centuries of stigma – and open vital doors in the search for a cureIt was with the pomp and intrigue of a Dan Brown novel that earlier this month Pope Francis made his way into the Aula Paolo VI audience hall, a room the size of an aeroplane hangar in Vatican City. Flanked by the flamboyant Swiss Guard and dark-suited men muttering into earpieces, he headed for an oversized chair on a stage in front of nearly 2,000 people. Many applauded, most gawped in disbelief.The pope was there to do something no other world leader has done before. He...
Source: Guardian Unlimited Science - May 27, 2017 Category: Science Authors: Dara Mohammadi in Vatican City Tags: Genetics Pope Francis Medical research Science The papacy Religion Catholicism World news Vatican Italy Source Type: news

Alzheimer's, Parkinson's, and Huntington's diseases share common crucial feature
A Loyola University Chicago study has found that abnormal proteins found in Alzheimer's disease, Parkinson's disease, and Huntington's disease all share a similar ability to cause damage when they... (Source: Parkinson's Disease News From Medical News Today)
Source: Parkinson's Disease News From Medical News Today - May 25, 2017 Category: Neurology Tags: Alzheimer's / Dementia Source Type: news

Alzheimer's, Parkinson's, and Huntington's diseases share common crucial feature
A Loyola University Chicago study has found that abnormal proteins found in Alzheimer's disease, Parkinson's disease, and Huntington's disease all share a similar ability to cause damage when they invade brain cells. The finding potentially could explain the mechanism by which Alzheimer's, Parkinson's, Huntington's, and other neurodegenerative diseases spread within the brain and disrupt normal brain functions. (Source: World Pharma News)
Source: World Pharma News - May 24, 2017 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Alzheimer's, Parkinson's, Huntington's diseases have common feature: Study
Researchers have discovered that abnormal proteins in common neurodegenerative diseases share the same ability to cause damage in brain cells. (Source: Health News - UPI.com)
Source: Health News - UPI.com - May 23, 2017 Category: Consumer Health News Source Type: news

Alzheimer's, Parkinson's, and Huntington's diseases share common crucial feature
(Loyola University Health System) A study has found that abnormal proteins found in Alzheimer's, Parkinson's and Huntington's diseases share a similar ability to cause damage when they invade brain cells. The finding suggests that an effective treatment for one neurodegenerative disease might work for other neurodegenerative diseases as well. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 23, 2017 Category: International Medicine & Public Health Source Type: news

Scientists to develop life-transforming drugs for Huntington's disease sufferers
(University of Sussex) Scientists at the University of Sussex have started work on a multi-million pound project to develop drugs to treat the debilitating loss of cognitive function associated with Huntington's disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 19, 2017 Category: International Medicine & Public Health Source Type: news

Ed Goldman: Two friends lead the regional fight against Huntington ’s disease, Part 2 of 2
Despite getting pregnant and married at a very early age, Dawn Doster made an achievement-strewn life for herself and her daughter after marrying her second husband (who, as we learned yesterday, adopted Doster ’s two-year-old daughter Yvette). She earned a bachelor's degree and an MBA, was a teacher and then the business operations chief for a federal agency. Despite the fact that her now-grown daughter has tested positive for Huntington’s disease, and her grandson is at risk for it, she says,… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - May 17, 2017 Category: American Health Authors: Ed Goldman Source Type: news

California city to stop using synthetic herbicides in favor or organic pesticides
(Natural News) Councilman Billy O’Connell of Huntington Beach, Orange County, California, has proposed a year-long pilot study to have portions of Central Park West use organic pesticides instead of synthetic ones. This move by the seaside city is meant to address the growing concern its citizens have with the many recorded adverse health effects synthetic... (Source: NaturalNews.com)
Source: NaturalNews.com - May 16, 2017 Category: Consumer Health News Source Type: news

15 Great White Sharks Off California Beaches Trigger Warnings
After a chilling sighting Wednesday, a Southern California sheriff’s deputy warned people from a helicopter to get out of the water because “you are paddleboarding next to approximately 15 great white sharks.” The lurking shadows of the big fish were spotted close to the surf line from Capistrano Beach in Dana Point to San Onofre State Beach, south of Los Angeles along the Orange County coast. Paddleboarders and swimmers were told to “exit the water in a calm manner.” The deputy added: “Please do not enter the water.” A swimmer reported a close encounter with one of the sharks, whi...
Source: Science - The Huffington Post - May 12, 2017 Category: Science Source Type: news

In Huntington's disease, traffic jams in the cell's control center kill brain cells
Working with mouse, fly and human cells and tissue, researchers report new evidence that disruptions in the movement of cellular materials in and out of a cell's control center -- the nucleus -- appear to be a direct cause of brain cell death in Huntington's disease, an inherited adult neurodegenerative disorder. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - May 4, 2017 Category: Science Source Type: news

Stealth begins SBT-20's Phase I/II trial in Netherlands to treat Huntington's disease
Stealth BioTherapeutics has begun the Phase I/II CHALLENGE-HD clinical trial of SBT-20 in the Netherlands to treat patients with early stage Huntington's disease. (Source: Drug Development Technology)
Source: Drug Development Technology - May 3, 2017 Category: Pharmaceuticals Source Type: news

Meadowcrest Apartments Sold; Chinese Garment Affiliate Buys Fourche Dam Property
Apartments, an industrial project and a store in Little Rock along with a dental development in Bryant and a closed restaurant in Conway all topped the $1 million sales mark. • Meadowcrest Apartments LLC, led by Don Marshall Jr., sold its namesake 122-unit complex at 5315 Stanley Drive to Colonial Park RBG LLC of West Plains, Missouri, for $2.8 million. • Ty Garments USA LLC, an affiliate of Suzhou Industrial Park Tianyuan Garments Co. Ltd. of China, bought the 89,516-SF 8909 Fourche Dam Pike project for more than $1.8 million. Seller? Joseph T. Ryerson & Son Inc. of Chicago. • The Alice Flynn 2005 Livin...
Source: Arkansas Business - Health Care - April 24, 2017 Category: American Health Source Type: news

Barbara Boxer will lobby for an environmentally controversial desalination plant in Huntington Beach
A Boston-based water development company is paying former Sen. Barbara Boxer to push for approval of a proposed seawater desalination plant that has been mired for years in environmental controversy.Boxer, a Democrat, will lobby the California Coastal Commission on behalf of Poseidon Water ’s private... (Source: Los Angeles Times - Science)
Source: Los Angeles Times - Science - April 20, 2017 Category: Science Authors: Bettina Boxall Source Type: news

Researchers identify link between birth defect, neurodegenerative diseases
A new study has found a link between neurological birth defects in infants commonly found in pregnant women with diabetes and several neurodegenerative diseases, including Alzheimer's, Parkinson's and Huntington's diseases. This is the first time this link has been identified; it may indicate a new way to understand, and perhaps treat, both neural tube defects and these diseases. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 10, 2017 Category: Science Source Type: news

URMC Plays Key Role in New Huntington ’s Drug
University of Rochester Medical Center researchers were instrumental in the U.S. Food and Drug Administration ’s recent approval of SD-809 (deutetrabenazine) to treat Huntington’s disease. Deutetrabenazine is the only the second drug authorized by the agency to treat this rare, inherited neurodegenerative disorder. (Source: University of Rochester Medical Center Press Releases)
Source: University of Rochester Medical Center Press Releases - April 5, 2017 Category: Universities & Medical Training Authors: University of Rochester Medical Center Source Type: news

FDA Clears Deutetrabenazine (Austedo) for Huntington's Chorea FDA Clears Deutetrabenazine (Austedo) for Huntington's Chorea
The orphan drug deutetrabenazine is a deuterated form of tetrabenazine and only the second drug approved for Huntington's disease.FDA Approvals (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - April 4, 2017 Category: Neurology Tags: Neurology & Neurosurgery News Alert Source Type: news

Teva gets FDA OK for rare disease treatment
The Food and Drug Administration approved Austedo, a drug developed by Teva Pharmaceutical Industries Ltd. to treat chorea associated with Huntington ’s disease. Huntington’s disease is a rare and fatal neurodegenerative disorder that affects more than 35,000 people in the United States. Chorea, a condition characterized by involuntary, random and sudden, twisting and/or writhing movements, is a physical manifestation of the disease that occ urs in about 90 percent of Huntingdon’s disease patients. “Chorea… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - April 4, 2017 Category: American Health Authors: John George Source Type: news

Teva wins FDA approval for Huntington's drug
(Reuters) - Israel-based Teva Pharmaceutical Industries Ltd said the U.S. Food and Drug Administration had approved its drug to treat chorea stemming from Huntington's disease, a fatal degenerative disorder. (Source: Reuters: Health)
Source: Reuters: Health - April 3, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Teva Announces FDA Approval of Austedo (deutetrabenazine) for the Treatment of Chorea Associated with Huntington ’s Disease
JERUSALEM--(BUSINESS WIRE)--Apr. 3, 2017-- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that the U.S. Food and Drug Administration (FDA) has approved Austedo (deutetrabenazine) tablets for the treatment of chorea... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - April 3, 2017 Category: Drugs & Pharmacology Source Type: news

This Waiter Helps a Customer With Huntington ’s Disease Every Week
A server's good deed went viral after another customer shared a heartwarming photo. (Source: WebMD Health)
Source: WebMD Health - March 31, 2017 Category: Consumer Health News Source Type: news

MassDevice.com +5 | The top 5 medtech stories for March 30, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. ADM Cleveland: Here are some top medtech manufacturing highlights The inaugural Advanced Design and Manufacturing is showcasing some of the medical device industry’s top design and manufacturing technology this week at th...
Source: Mass Device - March 30, 2017 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news

ADM Cleveland: Here are some top medtech manufacturing highlights
The inaugural Advanced Design and Manufacturing is showcasing some of the medical device industry’s top design and manufacturing technology this week at the Huntington Convention Center in Cleveland, Ohio. From manufacturing depression treating machines to dry ice cleaning machines, here are 8 exhibitors you should check out at ADM Cleveland. Next>> The post ADM Cleveland: Here are some top medtech manufacturing highlights appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - March 30, 2017 Category: Medical Equipment Authors: Danielle Kirsh Tags: Contract Manufacturing Laboratory Instruments/Laboratory Supplies ADM Cleveland Cincinnati Test Systems Cold Jet M&S Centerless Grinding MedTech NDH Medical Pleasant Precision Proto Labs SCS Coatings Sparton Source Type: news

Skin sensors provide insights into how to treat Parkinson ’s
[Image from MC10]A University of Rochester research team is using wearable sensors to indicate the best individualized treatment of Parkinson’s disease. Bernadette Mroz suffers from Parkinson’s. When her medication isn’t working, it makes it hard for her to function. “My world goes into a spin cycle. I cannot function mentally, emotionally or physically,” said Mroz in a University of Rochester news release. While a cure may not be available anytime soon, researchers are hoping to use wearable sensors to help control Mroz’s and other Parkinson’s sufferers’ tremors an...
Source: Mass Device - March 27, 2017 Category: Medical Equipment Authors: Danielle Kirsh Tags: Biotech Huntington's disease machine learning algorithms MedTech Parkinson's disease skin sensors University of Rochester wearable sensors Source Type: news

Early Huntington's disease: impulse control deficits but correct judgment regarding risky situations - Galvez V, Fernandez-Ruiz J, Bayliss L, Ochoa-Morales A, Hernandez-Castillo CR, Diaz R, Campos-Romo A.
BACKGROUND: Huntington's disease (HD) patients show alterations in decision making tasks. However, it is still uncertain if these deficits are due to poor judgment regarding risky situations, or to impulse control deficits. OBJECTIVE: To elucidate ... (Source: SafetyLit)
Source: SafetyLit - March 27, 2017 Category: Global & Universal Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

Cracking the code of Huntington's disease
(Ecole Polytechnique F é d é rale de Lausanne) Huntington's disease is caused by a gene mutation that causes a protein to build up in the brain. In a world first, EPFL scientists have synthesized and studied modified forms of a mutant part of the protein, deepening our understanding of how it contributes to the disease, and pointing to new therapeutic strategies for treating it. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 23, 2017 Category: Global & Universal Source Type: news

Study identifies brain cells involved in Pavlovian response
A new study has traced the Pavlovian response to a small cluster of brain cells -- the same neurons that go awry during Huntington's disease, Parkinson's disease and Tourette's syndrome. The research could one day help neuroscientists find new approaches to diagnosing and treating these disorders. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 22, 2017 Category: Science Source Type: news

Study identifies brain cells involved in Pavlovian response
(University of California - Los Angeles Health Sciences) A UCLA study has traced the Pavlovian response to a small cluster of brain cells -- the same neurons that go awry during Huntington's disease, Parkinson's disease and Tourette's syndrome. The research could one day help neuroscientists find new approaches to diagnosing and treating these disorders. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - March 22, 2017 Category: Global & Universal Source Type: news

Anti-Overdose Program Bars EMS from Getting Naloxone Kits
HUNTINGTON - Cabell EMS Director Gordon Merry expressed his frustration Thursday during a Cabell County Commission meeting over state guidelines that prohibit EMS departments from receiving naloxone kits distributed to the Cabell-Huntington Health Department through a federal grant. "It's very frustrating. Read More at The Herald Dispatch (Source: JEMS Patient Care)
Source: JEMS Patient Care - February 27, 2017 Category: Emergency Medicine Tags: Patient Care News Source Type: news

Anti-Overdose Program Bars EMS from Getting Naloxone Kits
HUNTINGTON - Cabell EMS Director Gordon Merry expressed his frustration Thursday during a Cabell County Commission meeting over state guidelines that prohibit EMS departments from receiving naloxone kits distributed to the Cabell-Huntington Health Department through a federal grant. "It's very frustrating. Read More at The Herald Dispatch (Source: JEMS: Journal of Emergency Medical Services News)
Source: JEMS: Journal of Emergency Medical Services News - February 27, 2017 Category: Emergency Medicine Tags: Patient Care News Source Type: news

Funding for study which could lead to new drug treatment for dementia diseases
(University of Plymouth) Scientists from Plymouth University Peninsula Schools of Medicine and Dentistry (PUPSMD) have received funding of more than £ 58,500 from BRACE, a charity which supports research into Alzheimer's disease, for a pilot study to investigate how a failure in our cells' 'recycling centre' could hold the key to new drug therapies for dementia diseases such as Parkinson's disease, Huntington's disease and dementia with Lewy bodies. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 24, 2017 Category: Global & Universal Source Type: news